Industry Projects
LATEST INDUSTRY PROJECTS
Lorcaserin hydrochloride (Lorcaserin) is an investigative oral treatment drug for obesity, and was discovered by Arena Pharmaceuticals (Arena), a clinical-stage biopharmaceutical company which also holds the drug patent.
Tamiflu - Oral Anti-Viral Treatment Agent
Tamiflu or oseltamivir is a prescription drug used for prophylaxis and treatment...
Tamiflu or oseltamivir is a prescription drug used for prophylaxis and treatment...
Plectasin NZ2114 - Novel Microbial Agent
Under development by Novozymes A/S, the Danish biotechnology company, plectasin NZ2114...
Under development by Novozymes A/S, the Danish biotechnology company, plectasin NZ2114...
- Abiraterone – Prostate Cancer Therapy
- Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
- Actemra - Biological Therapy for Rheumatoid Arthritis (RA)
- Alemtuzumab – Potential in Multiple Sclerosis
- Almorexant - Agent for Treatment of Sleep Disorders
- AM103 – Experimental Treatment for Respiratory Diseases
- APD125 - Therapy for Insomnia
- Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
- ASA404 Vascular Disrupting Agent for Solid Tumours
- Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy
- Elotuzumab – Anti-CS1 Antibody for Multiple Myeloma
- Erbitux (Cetuximab) - Biological Cancer Therapy
- ETC-216 - Phospholipid Therapy for Coronary Heart Disease (CHD) Patients UPDATED
- Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism
- Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes
- Idraparinux - Investigational Agent for the Treatment and Prevention of Thromboembolic Events
- Iloperidone - Atypical Antipsychotic for Schizophrenia
- INCB9471 – CCR5 Antagonist for Treatment of HIV Infection
- Istaroxime - Agent for Congestive Heart Failure
- Ixempra (Ixapebilone) – New Cancer Therapy UPDATED
- Lexapro – Treatment for Major Depressive Disorder in Adolescents
- Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis
- Liraglutide – Next-Generation Antidiabetic Medication
- Lorcaserin, Investigational Oral Anti-Obesity Drug NEW
- LY2140023 – Treatment of Schizophrenia
- Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application
- M6G, A New Morphine Derivative For Post-Operative Pain Relief
- Maraviroc - Therapy for Treatment of HIV Infection
- Merck Isentress - Emerging Therapy for Treatment of HIV Infection
- Motavizumab - New Biological Therapy for RSV Prevention
- Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia
- Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis
- T-705 - Antiviral Drug for Influenza
- Tamiflu - Oral Anti-Viral Treatment Agent NEW
- Taranabant CB1 Receptor Inverse Agonist for Management of Obe
- Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer UPDATED
- TB-402 – Therapeutic Monoclonal Antibody for VTE AND AF
- Telbivudine - Investigational Drug for Chronic Hepatitis B Infection
- Tesmilifene - Chemopotentiator for Cancer Therapies
- Tesofensine - Anti-Obesity Medication
- TRA-SCH-530348 -Oral Antiplatelet Agent
- Treximet - Next-Generation Treatment for Migraine
- Tygacil - Broad-Spectrum Antibiotic for Empiric Treatment of Serious Infections
- Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours
- Tysabri - Therapeutic Monoclonal Antibody (MAb) for the Treatment of Multiple Sclerosis
